AnaptysBio
ANAB
$25.98
Share price
-0.15%
Change (1 day)
22.72%
Change (1 year)
Categories
Operating Margin for AnaptysBio (ANAB)
Operating Margin as of May 2024 (TTM): -1,045.90%
According to AnaptysBio's latest financial reports and stock price the company's current Operating Margin is -1,045.90%. At the end of 2021 the company had an Operating Margin of -91.49%.
Operating Margin history for AnaptysBio from 2015 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -91.49% | 244.26% |
| 2020 | -26.57% | -97.82% |
| 2019 | -1,218.60% | -1.48% |
| 2018 | -1,236.96% | 311.36% |
| 2017 | -300.70% | 1077.95% |
| 2016 | -25.53% | -14.82% |
| 2015 | -29.97% | -234.39% |
| 2014 | 22.30% | -122.05% |
| 2013 | -101.13% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.